Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study

NCT07358897 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07358897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07358897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Not yet recruiting
Start date
February 16, 2026
Completion date
January 7, 2029
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

transgender